<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>The effects of type 1 and type 2 diabetes on bone and fracture risk</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">The effects of type 1 and type 2 diabetes on bone and fracture risk</h1>
<div class="graphic"><div class="figure"><div class="ttl">The effects of type 1 and type 2 diabetes on bone and fracture risk</div><div class="cntnt"><table cellspacing="0"><colgroup width="20%"></colgroup><colgroup span="2" width="40%"></colgroup> <tbody> <tr> <td class="subtitle1_left">Â </td> <td class="subtitle1_left">Type 1 diabetes</td> <td class="subtitle1_left">Type 2 diabetes</td> </tr> <tr> <td><strong>Physiologic profile</strong></td> <td> <ul> <li>Insulin deficiency</li> <li>Elevated blood glucose</li> </ul> </td> <td> <ul> <li>Insulin resistance</li> <li>Hyperinsulinemia</li> <li>Elevated blood glucose</li> </ul> </td> </tr> <tr class="highlight_lght_gray_text"> <td><strong>Usual age of diabetes onset</strong></td> <td> <ul> <li>Younger</li> <li>May affect peak bone mass</li> </ul> </td> <td> <ul> <li>Older</li> <li>Usually maturity onset</li> </ul> </td> </tr> <tr> <td><strong>BMD</strong></td> <td> <ul> <li>May be low</li> </ul> </td> <td> <ul> <li>May be normal to increased</li> </ul> </td> </tr> <tr class="highlight_lght_gray_text"> <td><strong>Fracture risk</strong></td> <td> <ul> <li>Increased</li> </ul> </td> <td> <ul> <li>Increased</li> </ul> </td> </tr> <tr> <td><strong>BMI and influence on bone</strong></td> <td> <ul> <li>Historically lower, but now resembles the distribution in the general population</li> </ul> </td> <td> <ul> <li>Usually high</li> <li>Increased load on skeleton</li> <li>Increased soft tissue may protect against impact</li> <li>Increased estrogen, leptin, and adiponectin production in adipose tissue; low testosterone levels in men</li> </ul> </td> </tr> <tr class="highlight_lght_gray_text"> <td><strong>Other mechanism(s) of bone fragility</strong></td> <td> <ul> <li>Hyperglycemia may cause increased urine calcium loss and inhibit bone formation</li> <li>Abnormal bone microarchitecture (predominantly trabecular)</li> <li>Bone turnover is usually low</li> <li>Advanced glycation end products may embrittle bone material and adversely impact bone remodeling</li> </ul> </td> <td> <ul> <li>Hyperglycemia may cause increased urine calcium loss and inhibit bone formation</li> <li>Abnormal bone microarchitecture (predominantly cortical)</li> <li>Bone turnover is usually low</li> <li>Advanced glycation end products may embrittle bone material and adversely impact bone modeling</li> </ul> </td> </tr> <tr> <td><strong>Diabetes pharmacotherapy</strong></td> <td> <ul> <li>Insulin has anabolic effect</li> </ul> </td> <td> <ul> <li>Adverse impact of thiazolidinediones and possibly SGLT2 inhibitors on bone strength</li> </ul> </td> </tr> <tr class="highlight_lght_gray_text"> <td><strong>Other diabetes-related complications</strong></td> <td colspan="2"> <ul> <li>Micro- and macrovascular complications may increase fracture risk by effects on bone (eg, by metabolic effects of nephropathy) or by association with an increased risk of falling (eg, secondary to visual loss, hypoglycemia, cerebrovascular disease, or neuropathy). Neuropathy-related local bone loss may increase fracture risk at the foot and ankle (Charcot foot).</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_footnotes">IGF-1: insulin-like growth factor 1; BMD: bone mineral density; BMI: body mass index; SGLT2: sodium-glucose cotransporter 2.</div><div class="graphic_reference">Sources:
<ol>
<li>Rakel A, Sheehy O, Rahme E, LeLorier J. Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab 2008; 34:193.</li>
<li>Adami S. Bone health in diabetes: considerations for clinical management. Curr Med Res Opin 2009; 25:1057.</li>
<li>Epstein S, Leroith D. Diabetes and fragility fractures - a burgeoning epidemic? Bone 2008; 43:3.</li>
<li>McCulloch D. Thiazolidinediones in the treatment of diabetes mellitus. In: UpToDate, Basow DS (Ed), UpToDate, Waltham, MA, 2013.</li>
</ol></div><div id="graphicVersion">Graphic 51539 Version 8.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
